Johns Hopkins Diabetes Guide
Tekturna
INDICATIONS
FDA
FDA
- Treatment of hypertension in adults and children 6 years of age and older.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- A Non-FDA labeled indication is the treatment of persistent proteinuria in patients with type II diabetes mellitus, hypertension and nephropathy.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 4, 2018
Citation
Pherson, Emily, and Donna Myers. "Tekturna." Johns Hopkins Diabetes Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547173/all/Tekturna.
Pherson , Myers D. Tekturna. Johns Hopkins Diabetes Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547173/all/Tekturna. Accessed June 1, 2023.
Pherson, ., & Myers, D. (2018). Tekturna. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547173/all/Tekturna
Pherson , Myers D. Tekturna [Internet]. In: Johns Hopkins Diabetes Guide. ; 2018. [cited 2023 June 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547173/all/Tekturna.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tekturna
ID - 547173
A1 - Pherson, Emily,Pharm.D.
AU - Myers,Donna,M.D.
Y1 - 2018/12/04/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547173/all/Tekturna
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
